Patient-Derived First Generation Xenografts of Non–Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized ChemotherapyXin Dong, Yuzhuo Wang, John Yee et al.|Clinical Cancer Research|2010Cited by 195
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier‐Luc Clermont, Cheryl D. Helgason, Francesco Crea et al.|Clinical Epigenetics|2016Cited by 78